SmartShopping, Inc. announced that it has received ¥1 billion in funding from Suzuken Co., Ltd.
August 16, 2022
Share
SmartShopping, Inc. announced that it has received ¥1,000 million in a round of funding from returning investor Suzuken Co., Ltd. on August 17, 2022. The company is raising funding through third party allocation method. The company issued non convertible preferred shares in the transaction.
The investor's shareholding ratio after the transaction is 15%.
Suzuken Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company operates in four business segments. The Pharmaceutical Wholesale segment sells pharmaceuticals, diagnostic drugs, and medical equipment and materials, among others. The Pharmaceutical Manufacturing segment manufactures pharmaceuticals and diagnostic drugs and others. The Insurance Pharmacy segment is engaged in dispensing operations based on prescriptions from medical institutions. The Medical-related Service and Others segment is engaged in the provision of manufacturer support services, such as the transportation of medicines and comprehensive support for the distribution of drugs for rare diseases; the nursing services; the manufacture of physiological examination equipment, such as electrocardiographic monitors and blood pressure monitors; as well as other services, such as the sale of medical books.
SUZUKEN CO., LTD. 
